Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rolf F Barth, Gong Wu, W Hans Meisen, Robin J Nakkula, Weilian Yang, Tianyao Huo, David A Kellough, Pravin Kaumaya, Claudia Turro, Lawrence M Agius & Balveen Kaur. (2016) Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors. OncoTargets and Therapy 9, pages 2769-2781.
Read now
Read now
Dongheon Lee, Eun-Sil Sung, Jin-Hyung Ahn, Sungwon An, Jiwon Huh & Weon-Kyoo You. (2015) Development of antibody-based c-Met inhibitors for targeted cancer therapy. ImmunoTargets and Therapy 4, pages 35-44.
Read now
Read now
Articles from other publishers (36)
Septiara Putri, Siti Rizny F. Saldi, Levina Chandra Khoe, Ery Setiawan, Amila Megraini, Benjarin Santatiwongchai, Ryan R. Nugraha, Vetty Y. Permanasari, Mardiati Nadjib, Sudigdo Sastroasmoro & Armansyah Armansyah. (2023) Cetuximab as first-line treatment for metastatic colorectal cancer (mCRC): a model-based economic evaluation in Indonesia setting. BMC Cancer 23:1.
Crossref
Crossref
Jocelyn Chan, Joyce Chan, Lily Shao, Scott S. Stawicki, Victoria C. Pham, Rob W. Akita, Marc Hafner, Lisa Crocker, Kebing Yu, James T. Koerber, Gabriele Schaefer & Laetitia Comps-Agrar. (2023) Systematic pharmacological analysis of agonistic and antagonistic fibroblast growth factor receptor 1 MAbs reveals a similar unique mode of action. Journal of Biological Chemistry 299:1, pages 102729.
Crossref
Crossref
Maria Caffo, Gerardo Caruso, Antonello Curcio, Roberta Laera, Concetta Crisafulli, Elena Fazzari, Marcello Passalacqua & Antonino Germanò. 2023. Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1. Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1
181
192
.
Maxim Sorokin, Marianna Zolotovskaia, Daniil Nikitin, Maria Suntsova, Elena Poddubskaya, Alexander Glusker, Andrew Garazha, Alexey Moisseev, Xinmin Li, Marina Sekacheva, David Naskhletashvili, Alexander Seryakov, Ye Wang & Anton Buzdin. (2022) Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data. BMC Cancer 22:1.
Crossref
Crossref
Sukhbir Singh, Neelam Sharma, Anil Bansal, Neha Kanojia, Sheshank Sethi, Jitender Madan & Rupinder Kaur Sodhi. 2021. Clinical Perspectives and Targeted Therapies in Apoptosis. Clinical Perspectives and Targeted Therapies in Apoptosis
153
207
.
Muzammal Hussain, Jinsong Liu, Gui-Zhen Wang & Guang-Biao Zhou. 2021. Tumor Microenvironment. Tumor Microenvironment
71
90
.
Konstantin Dobrenkov & Nai-Kong V. Cheung. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
486
499.e8
.
Alessandro Ottaiano, Stefania Scala, Nicola Normanno, Maria Napolitano, Monica Capozzi, Anna Maria Rachiglio, Cristin Roma, Anna Maria Trotta, Crescenzo D’Alterio, Luigi Portella, Carmela Romano, Antonino Cassata, Rossana Casaretti, Lucrezia Silvestro, Anna Nappi, Salvatore Tafuto, Antonio Avallone, Alfonso De Stefano, Mario Tamburini, Carmine Picone, Antonella Petrillo, Francesco Izzo, Raffaele Palaia, Vittorio Albino, Alfonso Amore, Andrea Belli, Ugo Pace, Massimiliano Di Marzo, Paolo Chiodini, Gerardo Botti, Gianfranco De Feo, Paolo Delrio & Guglielmo Nasti. (2019) Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol. BMC Cancer 19:1.
Crossref
Crossref
A. Courtenay Freeman, Simon R. Platt, Shannon Holmes, M. Kent, Kelsey Robinson, Elizabeth Howerth, Joe Eagleson, Alexandros Bouras, Milota Kaluzova & Constantinos G. Hadjipanayis. (2018) Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas. Journal of Neuro-Oncology 137:3, pages 653-663.
Crossref
Crossref
Nora S Sánchez, Gordon B Mills & Kenna R Mills Shaw. (2017) Precision oncology: neither a silver bullet nor a dream. Pharmacogenomics 18:16, pages 1525-1539.
Crossref
Crossref
Hironori Fujii, Hirotoshi Iihara, Akio Suzuki, Ryo Kobayashi, Nobuhisa Matsuhashi, Takao Takahashi, Kazuhiro Yoshida & Yoshinori Itoh. (2016) Hypomagnesemia is a reliable predictor for efficacy of anti-EGFR monoclonal antibody used in combination with first-line chemotherapy for metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology 77:6, pages 1209-1215.
Crossref
Crossref
Alexandros Bouras, Milota Kaluzova & Costas G. Hadjipanayis. (2015) Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles. Journal of Neuro-Oncology 124:1, pages 13-22.
Crossref
Crossref
Milota Kaluzova, Alexandros Bouras, Revaz Machaidze & Costas G. Hadjipanayis. (2015) Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles. Oncotarget 6:11, pages 8788-8806.
Crossref
Crossref
Sina Bondza, Jonas Stenberg, Marika Nestor, Karl Andersson & Hanna Björkelund. (2014) Conjugation Effects on Antibody–Drug Conjugates: Evaluation of Interaction Kinetics in Real Time on Living Cells. Molecular Pharmaceutics 11:11, pages 4154-4163.
Crossref
Crossref
Emmanuelle Vigne & Ingrid Sassoon. (2014) La montée en puissance des immunoconjugués en oncologie. médecine/sciences 30:10, pages 855-863.
Crossref
Crossref
Polina Weitzenfeld & Adit Ben-Baruch. (2014) The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. Cancer Letters 352:1, pages 36-53.
Crossref
Crossref
Juhua Zhou. (2014) Advances and Prospects in Cancer Immunotherapy. New Journal of Science 2014, pages 1-13.
Crossref
Crossref
Francesco Pinta, Agostino Ponzetti, Rosella Spadi, Laura Fanchini, Marcello Zanini, Caterina Mecca, Cristina Sonetto, Libero Ciuffreda & Patrizia Racca. (2014) Pilot Clinical Trial on the Efficacy of Prophylactic Use of Vitamin K1–Based Cream (Vigorskin) to Prevent Cetuximab-Induced Skin Rash in Patients With Metastatic Colorectal Cancer. Clinical Colorectal Cancer 13:1, pages 62-67.
Crossref
Crossref
Nai-Kong V. Cheung. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
508
518.e7
.
Mark X. SliwkowskiIra Mellman. (2013) Antibody Therapeutics in Cancer. Science 341:6151, pages 1192-1198.
Crossref
Crossref
Pavel Pitule, Miroslava Čedíková, Vladislav Třeška, Milena Králíčková & Václav Liška. (2013) Assessing colorectal cancer heterogeneity: one step closer to tailored medicine. Journal of Applied Biomedicine 11:3, pages 115-129.
Crossref
Crossref
Satoshi Fujii, Hideoki Uryu, Ken Akashi, Kensuke Suzuki, Manabu Yamazaki, Makoto Tahara, Ryuichi Hayashi & Atsushi Ochiai. (2012) Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx. International Journal of Clinical Oncology 18:3, pages 454-463.
Crossref
Crossref
M.M. Vickers, C.S. Karapetis, D. Tu, C.J. O'Callaghan, T.J. Price, N.C. Tebbutt, G. Van Hazel, J.D. Shapiro, N. Pavlakis, P. Gibbs, J. Blondal, U. Lee, J.M. Meharchand, R.L. Burkes, S.H. Rubin, J. Simes, J.R. Zalcberg, M.J. Moore, L. Zhu & D.J. Jonker. (2013) Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17. Annals of Oncology 24:4, pages 953-960.
Crossref
Crossref
Emanuel Cavazzoni, Walter Bugiantella, Luigina Graziosi, Maria Silvia Franceschini & Annibale Donini. (2012) Malignant ascites: pathophysiology and treatment. International Journal of Clinical Oncology 18:1, pages 1-9.
Crossref
Crossref
Urs A. MeyerUlrich M. ZangerMatthias Schwab. (2013) Omics and Drug Response. Annual Review of Pharmacology and Toxicology 53:1, pages 475-502.
Crossref
Crossref
Jeroen F. Vermeulen, Robert Kornegoor, Elsken van der Wall, Petra van der Groep & Paul J. van Diest. (2013) Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer. PLoS ONE 8:1, pages e53353.
Crossref
Crossref
Alexandros Garouniatis, Adamantia Zizi-Sermpetzoglou, Spyros Rizos, Alkiviadis Kostakis, Nikolaos Nikiteas & Athanasios G. Papavassiliou. (2012) FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk. International Journal of Colorectal Disease 28:1, pages 9-18.
Crossref
Crossref
Jingyu Diao, Homer Pantua, Hai Ngu, Laszlo Komuves, Lauri Diehl, Gabriele Schaefer & Sharookh B. Kapadia. (2012) Hepatitis C Virus Induces Epidermal Growth Factor Receptor Activation via CD81 Binding for Viral Internalization and Entry. Journal of Virology 86:20, pages 10935-10949.
Crossref
Crossref
Efat Azizi, Adam Kittai & Peter Kozuch. (2012) Antiepidermal Growth Factor Receptor Monoclonal Antibodies: Applications in Colorectal Cancer. Chemotherapy Research and Practice 2012, pages 1-15.
Crossref
Crossref
G Smith, M T H Ng, L Shepherd, C S Herrington, C Gourley, M J Ferguson & C R Wolf. (2012) Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer. British Journal of Cancer 107:8, pages 1327-1336.
Crossref
Crossref
D Sidler, A Brockmann, J Mueller, U Nachbur, N Corazza, P Renzulli, A Hemphill & T Brunner. (2011) Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase–Bim axis and reveals glutathione-S-transferase P1 as Achilles’ heel. Oncogene 31:37, pages 4095-4106.
Crossref
Crossref
Youjun Chen, Cecile Chalouni, Christine Tan, Robyn Clark, Rayna Venook, Rachana Ohri, Helga Raab, Ron Firestein, William Mallet & Paul Polakis. (2012) The Melanosomal Protein PMEL17 as a Target for Antibody Drug Conjugate Therapy in Melanoma. Journal of Biological Chemistry 287:29, pages 24082-24091.
Crossref
Crossref
Jörgen Carlsson. (2012) Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors. Tumor Biology 33:3, pages 653-659.
Crossref
Crossref
Sharon Marsh. (2012) Research Highlights: Highlights from the latest articles in colorectal cancer pharmacogenomics. Pharmacogenomics 13:7, pages 743-746.
Crossref
Crossref
M. Ocker & M. Höpfner. (2012) Apoptosis-Modulating Drugs for Improved Cancer Therapy. European Surgical Research 48:3, pages 111-120.
Crossref
Crossref
Jeffrey T. Yorio, Nishin A. Bhadkamkar, Bryan K. Kee & Christopher R. Garrett. (2012) A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas. International Journal of Surgical Oncology 2012, pages 1-7.
Crossref
Crossref